Clinical Trials · NCT01313273
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
- Phase
- Phase 3
- Recruitment status
- Terminated
- Sponsor
- Ipsen
- Enrollment
- 3
- Start date
- Jun 2011
- Locations
- 1 site, Italy
- Primary endpoint
- Progression-free Survival